A Study to Evaluate the Drug-drug Interactions (DDIs) of DBPR108 With Warfarin Sodium, Digoxin, Probenecid in Healthy Subjects

NCT05045313 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Warfarin sodium tablets
DRUG: Digoxin tablet
DRUG: Probenecid tablets
DRUG: DBPR108 tablets

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.